TY  - GEN
AU  - Ma,B B Y
AU  - Kam,M K M
AU  - Leung,S F
AU  - Hui,E P
AU  - King,A D
AU  - Chan,S L
AU  - Mo,F
AU  - Loong,H
AU  - Yu,B K H
AU  - Ahuja,A
AU  - Chan,A T C
TI  - A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
SN  - 1569-8041
PY  - 2012///0907
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carcinoma
KW  - Cetuximab
KW  - Chemoradiotherapy
KW  - Cisplatin
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Feasibility Studies
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Nasopharyngeal Carcinoma
KW  - Nasopharyngeal Neoplasms
KW  - pathology
KW  - Neoplasm Recurrence, Local
KW  - therapy
KW  - Neoplasm Staging
KW  - Radiotherapy, Intensity-Modulated
KW  - methods
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1093/annonc/mdr401
ER  -